Brensocatib Impurity 31 | CAS 1315000-82-8 - Request Quote
Brensocatib Impurity 31
| SZ CAT No: | SZ-B145037 |
| CAS No | 1315000-82-8 |
| Mol.F. | C6H13NO2 |
| Mol.Wt. | 131.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Brensocatib Impurity 31 is chemically (S)-(1,4-oxazepan-2-yl)methanol. Brensocatib Impurity 31 is supplied with detailed characterization data compliant with regulatory guideline. Brensocatib Impurity 31 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Brensocatib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1315000-82-8
Purchase 1315000-82-8
Order 1315000-82-8
Enquire 1315000-82-8
price of 1315000-82-8
1315000-82-8 Supplier
1315000-82-8 Manufacturer
1315000-82-8 Exporter
buy high quality Brensocatib Impurity 31
Purchase Brensocatib Impurity 31
Brensocatib Impurity 31 suppliers
Brensocatib Impurity 31 manufacturers
Brensocatib Impurity 31 price
Order Brensocatib Impurity 31
Enquire Brensocatib Impurity 31
Brensocatib Impurity 31 cost
Brensocatib Impurity 31 Supplier
Brensocatib Impurity 31 Distributor
Brensocatib Impurity 31 for Method Validation
Brensocatib Reference Standard
Brensocatib Impurity 31 for ANDA Filing
Brensocatib Impurity 31 for Forced Degradation Studies
Brensocatib Impurity 31 Identification Standards
Brensocatib Impurity 31 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.